ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

DCD vs DBD Pancreas Transplant Outcome – A Comprehensive Registry Analysis

A. C. Gruessner1, S. J. Saggi2, R. Gruessner1

1SUNY Downstate Medical Center, Brooklyn, NY, 2Medicine, SUNY Downstate Medical Center, Brooklyn, NY

Meeting: 2022 American Transplant Congress

Abstract number: 428

Keywords: Donors, non-heart-beating, Pancreas transplantation, Risk factors

Topic: Clinical Science » Pancreas » 65 - Pancreas and Islet: All Topics

Session Information

Session Name: Pancreas and Islet: All Topics

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 3:30pm-5:00pm

 Presentation Time: 3:40pm-3:50pm

Location: Hynes Room 210

*Purpose: Pancreas transplantation offers long-term independence from insulin injections for patients with labile diabetes mellitus. After a decade of decline (2004-2015), the number of pancreas transplants has finally increased again, particularly in the simultaneous pancreas and kidney (SPK) category due to excellent outcome. However, the number of suitable donor pancreata is limited primarily because of donor age limitations and organ quality. Hence, pancreata with extended donor criteria are rarely considered for transplantation. The purpose of this study was to compare transplant outcome between donation after cardiac death (DCD) vs donation after brain death (DBD).

*Methods: All primary simultaneous pancreas/kidney (SPK) transplants between 1/1/2011 and 12/31/2020 were included. Comprehensive descriptive analyses of patient, donor, and transplant characteristics were performed as well as analysis of follow-up status. Patient and graft survival was assessed using the Kaplan-Meier method. A risk assessment model was developed using Cox regression.

*Results: Out of 7,621 primary SPK transplants only 3% came from DCD donors. DCD donors were on average younger than DBD donors, and more often White. pDRI was significantly higher in DCD donors but removing the DCD factor from the formula revealed no differences (Figure 1). Significantly more high-volume centers accepted DCD pancreas donors. The same finding was noted for the kDPI. SPK patient and graft survival was comparable between DCD and DBD donors and was excellent in both groups (Figure 2). The only difference was noted in DCD kidneys with a significantly higher delayed graft function rate: 23% for DCD vs 7.4% for DBD (p<0.0001). Of note, the delayed graft function rate was significantly lower for DCD kidney grafts shipped on pump (p< 0.05) but was still significantly higher compared to DBD kidneys. A multivariable risk analysis for pancreas and kidney graft survival identified only donor and recipient age, recipient BMI, and center volume, but not DCD donor type, as risk factors.

*Conclusions: Due to high organ quality standards, a pancreas graft is less often accepted for transplantation than a kidney graft. Our analysis showed that outcome of pancreas transplants from DCD donors are equivalent to DBD donors. We also noted that donor management advancements such as normo- or hypothermic perfusion, persufflation of both pancreas and kidney significantly widen the donor pool and improve DCD transplant outcome.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gruessner AC, Saggi SJ, Gruessner R. DCD vs DBD Pancreas Transplant Outcome – A Comprehensive Registry Analysis [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/dcd-vs-dbd-pancreas-transplant-outcome-a-comprehensive-registry-analysis/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences